Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
48
ATNM Quote, Financials, Valuation and Earnings
Last price:
$1.19
Seasonality move
:
5.17%
Day range:
$1.23 - $1.30
52-week range:
$1.03 - $10.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.06x
Volume:
187.7K
Avg. volume:
159.3K
1-year change:
-80.74%
Market cap:
$40.6M
Revenue:
$81K
EPS (TTM):
-$1.39
Earnings Data
Next earnings date for ATNM
Apr 25
2025
Most recent earnings per share
-$0.37
Missed by $0.00
(Nov 14/2024)
Consensus Estimate
-$0.37
(Nov 14/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ATNM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 04/25/2025 | Q1 | -- | -- | -- | -$0.38 | -- |
| 12/31/2024 | Q4 | -- | -- | -- | -$0.39 | -- |
| 11/14/2024 | Q3 | -- | -- | -$0.37 | -$0.37 | -$0.00 |
| 08/05/2024 | Q2 | -- | -- | -$0.38 | -$0.40 | $0.02 |
| 04/26/2024 | Q1 | -- | -- | -$0.31 | -$0.52 | $0.21 |
| 12/31/2023 | Q4 | -- | $81K | -$0.33 | -$0.54 | $0.21 |
| 11/02/2023 | Q3 | $460K | -- | -$0.49 | -$0.57 | $0.08 |
| 08/14/2023 | Q2 | -- | -- | -$0.58 | -$0.49 | -$0.09 |
| 05/15/2023 | Q1 | -- | -- | -$0.43 | -$0.43 | $0.00 |
| 12/31/2022 | Q4 | $1M | -- | -$0.43 | -$0.34 | -$0.09 |
| 11/14/2022 | Q3 | -- | $45K | -$0.38 | -- | -- |
| 08/12/2022 | Q2 | -- | $45K | -$0.33 | -- | -- |
| 05/13/2022 | Q1 | -- | $940K | -$0.23 | -- | -- |
| 02/24/2022 | Q4 | -- | $23K | -$0.36 | -- | -- |
| 11/12/2021 | Q3 | -- | $233K | -$0.30 | -- | -- |
| 07/30/2021 | Q2 | -- | $266K | -$0.25 | -- | -- |
| 05/14/2021 | Q1 | -- | $622K | -$0.29 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.37 | -- | -- |
| 10/23/2020 | Q3 | -- | -- | -$0.36 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.41 | -- | -- |
| 05/08/2020 | Q1 | -- | -- | -$0.98 | -- | -- |
| 03/19/2020 | Q4 | -- | -- | -$0.80 | -- | -- |
| 10/28/2019 | Q3 | -- | -- | -$1.21 | -- | -- |
| 08/09/2019 | Q2 | -- | -- | -$1.00 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$1.50 | -- | -- |
| 03/19/2019 | Q4 | -- | -- | -$1.50 | -- | -- |
| 11/09/2018 | Q3 | -- | -- | -$1.80 | -- | -- |
| 08/09/2018 | Q2 | -- | -- | -$1.20 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$2.10 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$1.80 | -- | -- |
| 11/03/2017 | Q3 | -- | -- | -$2.70 | -- | -- |
| 08/04/2017 | Q2 | -- | -- | -$3.60 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$4.20 | -- | -- |
| 03/17/2017 | Q4 | -- | -- | -$3.60 | -- | -- |
| 10/28/2016 | Q3 | -- | -- | -$4.20 | -- | -- |
| 07/29/2016 | Q2 | -- | -- | -$4.20 | -- | -- |
| 05/13/2016 | Q1 | -- | -- | -$3.00 | -- | -- |
| 04/04/2016 | Q4 | -- | -- | -$4.80 | -- | -- |
| 11/27/2015 | Q3 | -- | -- | -$3.00 | -- | -- |
| 08/14/2015 | Q2 | -- | -- | -$6.00 | -- | -- |
| 03/31/2015 | Q1 | -- | -- | -$2.70 | -- | -- |
Actinium Pharmaceuticals Earnings Questions
-
How Much did Actinium Pharmaceuticals Generate in Revenue Last Quarter?
Actinium Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Actinium Pharmaceuticals Beat Earnings Last Quarter?
Actinium Pharmaceuticals announced earnings per share of -$0.37 which represents a miss of analyst forecast a -$0.37 per share.
-
Is Actinium Pharmaceuticals Profitable?
Actinium Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Actinium Pharmaceuticals EPS Next Year?
Actinium Pharmaceuticals's earnings are forecast to decrease from -$1.83 per share to -$1.43 per share next year representing a decrease of -61.89%.
-
When is Actinium Pharmaceuticals's Earnings Date?
Actinium Pharmaceuticals's next earnings date is April 25, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
